Signature Estate & Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Signature Estate & Investment Advisors's BMY Position: Q2 2026 in Review
Signature Estate & Investment Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 4,048 shares — an estimated $246K sold.
Signature Estate & Investment Advisors first reported a position in BMY in Q2 2016 and held it in 22 quarters. The position peaked at $11.7M in Q1 2022. 1,717 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Signature Estate & Investment Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
- Signature Estate & Investment Advisors sold 4,048 Bristol-Myers Squibb shares in Q2 2026, an estimated $246K.
- Signature Estate & Investment Advisors first reported a position in Bristol-Myers Squibb in Q2 2016 and held it in 22 quarters.
- Signature Estate & Investment Advisors's Bristol-Myers Squibb position peaked at $11.7M in Q1 2022.
- 1,717 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Signature Estate & Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.